Targeting MCL-1 in cancer: current status and perspectives

H Wang, M Guo, H Wei, Y Chen - Journal of hematology & oncology, 2021 - Springer
Abstract Myeloid leukemia 1 (MCL-1) is an antiapoptotic protein of the BCL-2 family that
prevents apoptosis by binding to the pro-apoptotic BCL-2 proteins. Overexpression of MCL …

Why do BCL-2 inhibitors work and where should we use them in the clinic?

J Montero, A Letai - Cell Death & Differentiation, 2018 - nature.com
Intrinsic apoptosis is controlled by the BCL-2 family of proteins but the complexity of intra-
family interactions makes it challenging to predict cell fate via standard molecular biology …

Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia

AE Tron, MA Belmonte, A Adam, BM Aquila… - Nature …, 2018 - nature.com
Mcl-1 is a member of the Bcl-2 family of proteins that promotes cell survival by preventing
induction of apoptosis in many cancers. High expression of Mcl-1 causes tumorigenesis and …

BRD-810 is a highly selective MCL1 inhibitor with optimized in vivo clearance and robust efficacy in solid and hematological tumor models

U Rauh, G Wei, M Serrano-Wu, G Kosmidis… - Nature Cancer, 2024 - nature.com
The MCL1 gene is frequently amplified in cancer and codes for the antiapoptotic protein
myeloid cell leukemia 1 (MCL1), which confers resistance to the current standard of care …

Cell death and cell death responses in liver disease: mechanisms and clinical relevance

T Luedde, N Kaplowitz, RF Schwabe - Gastroenterology, 2014 - Elsevier
Hepatocellular death is present in almost all types of human liver disease and is used as a
sensitive parameter for the detection of acute and chronic liver disease of viral, toxic …

[HTML][HTML] Apoptosis and necrosis in the liver

ME Guicciardi, H Malhi, JL Mott… - Comprehensive …, 2013 - ncbi.nlm.nih.gov
Because of its unique function and anatomical location, the liver is exposed to a multitude of
toxins and xenobiotics, including medications and alcohol, as well as to infection by …

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5

L Liu, Y Cao, C Chen, X Zhang, A McNabola, D Wilkie… - Cancer research, 2006 - AACR
Angiogenesis and signaling through the RAF/mitogen-activated protein/extracellular signal-
regulated kinase (ERK) kinase (MEK)/ERK cascade have been reported to play important …

Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration

RM Perciavalle, DP Stewart, B Koss, J Lynch… - Nature cell …, 2012 - nature.com
Abstract MCL-1, an anti-apoptotic BCL-2 family member that is essential for the survival of
multiple cell lineages, is also among the most highly amplified genes in cancer. Although …

Bcl-2 antiapoptotic family proteins and chemoresistance in cancer

S Maji, S Panda, SK Samal, O Shriwas, R Rath… - Advances in cancer …, 2018 - Elsevier
Cancer is a daunting global problem confronting the world's population. The most frequent
therapeutic approaches include surgery, chemotherapy, radiotherapy, and more recently …

[PDF][PDF] Effects of microRNA‐29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma

Y Xiong, JH Fang, JP Yun, J Yang, Y Zhang… - …, 2010 - Wiley Online Library
Based on microarray data, we have previously shown a significant down‐regulation of miR‐
29 in hepatocellular carcinoma (HCC) tissues. To date, the role of miR‐29 deregulation in …